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(57) ABSTRACT 
The present invention provides a device for detecting the 
presence of an analyte, such as for example, a lightweight 
device, including: a sample chamber having a fluid inlet port 
for the influx of the analyte; a fluid concentrator in flow 
communication with the sample chamber wherein the fluid 
concentrator has an absorbent material capable of absorbing 
the analyte and capable of desorbing a concentrated analyte; 
and an array of sensors in fluid communication with the 
concentrated analyte to be released from the fluid concen- 
trator. 
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TRACE LEVEL DETECTION OF ANALYTES 
USING ARTIFICIAL OLFACTOMETRY 
CROSS-REFERENCES TO RELATED 
Similarly, other volatile substances can interfere with the 
readings of the VSC. 
A second device for the detection of breath and odors 
associated therewith is based on zinc-oxide thin film semi- 
APPLICATIONS s conductor technology and has recently been developed for 
The present application is a continuation of U.S. patent measuring VSC (see, Shimura M et a L  J.  Periodontal. 
application No. 091335,425, filed Jun. 17, 1999, now U.S. 67396-402 (1994)). New ~ O s m o s  Electric CO. (Osaka, 
pat, N ~ ,  6,244,096, which claims priority to u,s, provi- Japan) manufactures this device. This device, however, is 
sional Applications ser, N ~ ,  601090,012, filed juri, 19,1998, limited because it is susceptible to interference from organic 
and 601091,179, filed Jun. 30,1998, the disclosures of which 10 vapors unrelated to oral ndodor  (see, Yaegaki K, In 
are incorporated herein by reference in their entirety. Rosenberg, "Bad Breath: Research Perspectives," Proceed- 
ings of the First International Workshop on Oral Malodor, 
Ramot Publishing, Tel Aviv University pp. 41-54 (1993)) 
87-108 (1995)). 
Another analysis for breath detection is a test based on the 
The research carried out in the subject application was enzyme substrate benzoYl-DL-arginine-naPhthYlamine 
sponsored, in part, by grants from: ARO (DAAG-55-97-1- @ANA) (see, Loesche et al., J .  Clin. Microbial. 
0187); DMPA ( ~ ~ ~ ~ 6 0 - 9 7 - ~ - 9 5 0 3 ) ;  and NASA (49- 28:1551-1559 (1991); and Loesche etal. J .  Periodontol., 
244-30002-0-8280), and is subject to the provisions of 61:189-196 (1991)). This test is marketed -under the brand 
public L~~ 96-517 (35 u,s,c, 5 202). The government may 20 name Peroscan and is available from Oral-B Laboratories 
have certain rights in any patents issuing on this application. (Redwood City, Calif.). ScraPings from the tongue, saliva, Or 
plaque samples are deposited directly on a reagent card. 
BACKGROUND OF THE INVENTION Following substrate addition, a blue spot develops if anaer- 
~n artificial olfactory system is a device that is capable of obes are present. Studies have shown that BANAresults are 
detecting a wide variety of analytes in fluids such as vapors, 25 not highly correlated with VSC measurements and that the 
gases and liquids. The device comprises an array of sensors test is often detecting other analYtes (see, KozlovskY et al.9 
that in the presence of an analyte produces a response. The J.  Dent. Res., 73:1036-1042 (1994)). 
device produces a unique signature output for a particular It has been estimated that at least 50% of the PoPulation 
analyte. Using pattern recognition algorithms, the output suffers from chronic oral ndodor  (see, BosY, J.  Can. Dent. 
signature, such as an electrical response, can be correlated 30 Assoc. 63:196-201 (1997)). A significant fraction of the 
and to a particular analyte or mixture of sub- population is worried about bad breath, even though there is 
stances that are known. By comparing the unknown signa- usually no underlying disease (see, Iwakura et al.9 J.  Dent. 
ture with the stored or known signatures, the analyte can be Res. 711568-1574 1 (1994)). Food, of course, is another 
detected, identified and quantified. cause of oral malodors. However, there are many people 
35 who have an unwarranted phobia of bad breath. The size of 
trace amounts of analytes. However, in certain instances, the the market for breath fresheners, chewing gums, and mouth 
analytes are found at levels that are too low to register a rinses is an indicator Of this propensity. 
STATEMENT AS TO RIGHTS TO INVENTIONS 
MADE UNDER FEDERALLY SPONSORED 
RESEARCH AND DEVELOPMENT IS 
There are many instances where it is desirable to 
robust signal by direct exposure to currently available sen- breath measurements, respira- 
SOTS, In headspace analysis of applications in agricultural, tory devices for anesthetic and respiratory gas mixtures must 
wine, tobacco, perfume, plastics, and the food industries, the 40 be monitored at very low concentrations Of analytes. Medi- 
In addition to 
detection and classification of trace levels of gases are cal devices mix the anesthetic with breathing gas prior to 
present in the sub part per million (ppm) range, making delivery to the patient. In an anesthetic device, it is impera- 
detection dificult, Moreover, in residue analysis of pesti- tive that the concentration of the anesthetic, gas flow and 
meet federal guidelines, For certain crops, these residues are 45 certainty. In most instances, the anesthetic amounts are at 
present on the crops in the part per billion levels (ppb). very low concentration levels. 
One approach to increase sensitivity to certain analytes is Another potential application wherein the detection of to use selective filters or membranes. For instance, U.S. Pat. trace levels of analytes is important is the diagnosis of No. 5,841,021, which issued to De Castro et al., discloses an patients conditions from an analysis of their breath. Marker 
SO electrochemical gas sensor that has a catalytically active gases such as hydrogen sulfide and methyl mercaptan, which sensor electrode, a reference electrode and a permselective are important in diagnosing the presence of oral or lung filter or membrane layer. The filter is made of a material that conditions from the breath of human patients, often exist in provides for molecular specificity of certain gases, such as concentrations of 0.01-1 parts per million (or lower). carbon monoxide. The membrane allows the sensors to be However, the threshold detection levels of currently known ss selective to the chemical analyte of interest. The filter only sensors are in the range of 1-100 parts per million. allows the analytes of interest to contact the sensor. By 
malodors is the Halimeter, which is commercially available sor becomes selective and thus sensitive to the analyte 
from Interscan Corp. (Chatsworth, Calif.). Using an elec- of interest, 
trochemical cell that is sensitive to volatile sulfur com- 6o In addition, u,s, Pat, No, 5,057,436, which issued to Ball, 
gases, such as ammonia, using a metal oxide semiconductor according to the following reactions: 
and an electrochemical sensor. Disposed between the two 
sensors is an absorber having an absorbent that reacts with 
In view of the foregoing, what is needed in the art is a 
vapor concentrator for an array of sensors, especially for an 
tides on crops, the trace levels of certain herbicides must amounts Of the mixture and gases be known with 
the most device for detecting Ora' removing interfering substances through filtration, the sen- 
pounds (vsc), the device can Oxidize the vsc at the anode discloses a method and apparatus for detection of toxic 
H2S+S+2H'2e- 
2CH3SH+CH3-SS-CH3+S+2H'2e- 
CH3S-CH3+2H20+2CH30H+S+2H'+2e- 65 ammonia. 
However, one obvious drawback is that the Halimeter 
cannot distinguish between volatile sulfur compounds. 
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electronic nose sensor array. In addition, methods are needed 
to detect odors and diagnose medical conditions. The present 
invention fulfills these and other needs. 
SUMMARY OF THE INVENTION 
In certain instances, it is desirable to measure trace 
amounts of analytes using sensor array technology. The 
present invention increases the sensitivity to such analytes 
by a large factor, and thus allows for the use of existing 
sensor systems for applications where an increase in sensi- 
tivity renders them more effective. As such, in certain 
aspects, the present invention provides a device for detecting 
the presence of an analyte, the device comprising: a sample 
chamber having a fluid inlet port for the influx of the analyte; 
a fluid concentrator in flow communication with the sample 
chamber, wherein the fluid concentrator has an absorbent 
material capable of absorbing the analyte and capable of 
desorbing a concentrated analyte; and an array of sensors in 
fluid communication with the concentrated analyte. In cer- 
tain preferred embodiments, the device further includes a 
detector operatively associated with each sensor that pro- 
vides a response in the presence of the analyte. 
The absorbent material of the fluid concentrator can be, 
but is not limited to, a nanoporous material, a microporous 
material, a chemically reactive material, a nonporous mate- 
rial and combinations thereof In certain instances, the absor- 
bent material can concentrate the analyte by a factor that 
exceeds a factor of about lo5, and more preferably by a 
factor of about 10’ to about lo4. Using the device of the 
present invention, the analyte can be concentrated from an 
initial sample volume of about 10 liters and then desorbed 
into a concentrated volume of about 10 milliliters or less, 
before being presented to the sensor array. 
In another embodiment, removal of background water 
vapor is conducted in conjunction, such as concomitantly, 
with the concentration of the analyte. Once the analyte is 
concentrated, it can be desorbed using a variety of 
techniques, such as heating, purging, stripping, pressuring or 
a combination thereof. 
In yet another aspect, the present invention provides 
methods for detecting or diagnosing, for example, 
infections, lung cancer, oral infections and halitosis using a 
breath sample of a mammal. Preferably, the mammal is a 
human being. In other embodiments, the present invention 
provides methods for other medical applications, such as 
those involving the detection of marker gas(es) in mamma- 
lian breath as well as odors from potentially infected areas 
of the skin. 
In still yet another aspect, the present invention provides 
methods and devices for the process control of anesthetic 
gases of clinical interest. Using the apparatus of the present 
invention, monitoring and quantitating anesthetics is readily 
accomplished. 
These and other embodiments and advantages will be 
readily apparent when read with the accompany drawings 
and the detailed description of the invention which follows. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a cross-sectional view of a breath collector and 
FIG. 2 is a cross-sectional view of a breath collector and 
FIG. 3 is a head space analyzer of the present invention. 
FIG. 4 is a block diagram of a vaporizing system of the 
concentrator of the present invention. 
concentrator of the present invention. 
present invention. 
FIG. 5 illustrates various response patterns obtained using 
the devices of the present invention. Panel A illustrates the 
responses of 32 sensors to anevobius (Bacl), gingivalis 
(Bac2) and a control; Panel B illustrates responses of 32 
s sensors to anevobius (Bacl), gingivalis (Bac2) and a control 
(Expanded y- axis). 
FIG. 6 illustrates the results of principle component 
analysis on a data set of Ps anevobius (Bacl) and P gingi- 
valis bacteria (Bac2) plus the control (the medium in which 
FIG. 7 illustrates the response of sensors in the presence 
FIG. 8 illustrates the results of the response of sensor 
10 the bacteria were grown). 
of 3 percent halothane. 
15 array in the presence of halothane. 
DETAILED DESCRIPTION OF THE 
INVENTION AND PREFERRED 
EMBODIMENTS 
20 I. The Device 
In one aspect, the present invention allows existing sensor 
systems to be more effective and efficient by providing 
enhancements in the detection sensitivity to trace analytes. 
As such, in one embodiment, the present invention provides 
a device for detecting the presence of an analyte in a fluid, 
comprising: 
a) a sample chamber having a fluid inlet port for the influx 
of the analyte; 
b) a fluid concentrator in flow communication with the 
sample chamber, the fluid concentrator having an 
absorbent material capable of absorbing the analyte and 
capable of desorbing a concentrated analyte; and 
c) an array of sensors in fluid communication with the 
In preferred embodiments, the device further comprising 
a detector operatively associated with each sensor that 
provides a response in the presence of an analyte. In certain 
embodiments, the sample chamber is designed for the col- 
40 lection of mammalian breath. Under certain conditions, 
mammalian breath contains marker gases indicative of cer- 
tain infections, disorders and medical conditions and the 
devices of the present invention can be used to detect such 
marker gases. In certain aspects, the sample chamber is a 
45 breath collector and concentrator (BCC) and is fabricated to 
collect the breath of a mammal. Preferably, the mammal is 
a human being, although the BCC can be fabricated to 
collect the breath of other mammals such as cows, sheep, 
horses, dogs, cats, hogs, etc. The BCC is convenient to use 
SO and in certain instances is a portable handheld device with 
a suitable handle portion for convenient use. 
With reference to FIG. 1, in certain embodiments, the 
sample chamber is a cylindrical reservoir having an inlet 
port (10) for the influx of gas, such as breath, and an outlet 
ss port (19) for the exhaust of breath The BCC has a first end 
and a second end. The cylindrical container (12) extends 
between the first end and the second end, and the cylindrical 
container has an open interior chamber (13). 
The first end of the body is open for access to the interior 
60 chamber and functions as a breath inlet port and is vented by 
a breath exhaust. The breath inlet port optionally contains a 
disposable adapter for multiple use. A concentrator portal 
(14) opens into the interior chamber and is in flow commu- 
nication with the fluid concentrator. The fluid concentrator 
65 (15) comprises an absorbent material capable of absorbing 
the analyte and capable of desorbing a concentrated analyte. 
In certain embodiments, valves control the breath flow so the 
2s 
30 
35 concentrated analyte. 
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sample of breath within the chamber can be directed to the 
fluid concentrator. The fluid concentrator optionally contains 
a second exhaust or exit port. 
A valve (16) is mounted anterior to the outlet Port with 
sufficient force to maintain the vent closed except when the 5 
mammal is exhaling into the chamber. Optionally, the fluid 
desorbing a concentrated analyte. As illustrated in FIG. 1, 
interior chamber and is in fluid communication with the 
desorbed concentrated analyte and the sensor array (11). In 
ing includes a robotic armature system. In general, these 
systems include automated workstations like the automated 
apparatus developed by Takeda Chemical Industries, LTD. 
(Osaka, Japan) and many robotic systems utilizing robotic 
(Zymate 11, Zymark Corporation, Hopkinton, M ~ ~ ~ , ;  
Orca, Hewlett-Packard, Palo Alto, Calif.), which mimic the 
and implementation of modifications to these devices (if 
i o  skilled in the relevant art. 
concentrator is jacketed (17) with a heater for the PUTose Of manual operations performed by a technician. The nature 
the BCC has a array porta' (18) that 'pens into the any) so that they can operate will be apparent to persons 
certain embodiments, the array is disposed down- In 'peration, a Of the gas to be as 
stream of the inlet port and the concentrator portal, In other human breath, is introduced into a chamber where it 
embodiments, the array is disposed between the inlet is transported by means of convention into the vicinity of the 
port and the concentrator portal (not shown), certain sorbent material. Suitable transporting means include, but 
embodiments, the BCC has an adapter to provide breath 15 are not limited to, a fan, an air pump, or it can be means for 
from the nostril(s) to avoid cross-contamination from the heating the cylindrical container (12) to create a convective 
mouth. air flow between the inlet and the outlet. The sorbent 
In certain aspects, the BCC can be a desktop model. As material is chosen from known materials designed for the 
illustrated in FIG. 2, the first end (24) of the BCC (20) is purpose of sorbing gases, vapors, and the like. In certain 
open for access to the interior chamber (22) and functions as 20 embodiments, the sorbent material includes, but is not 
a breath inlet port and is vented by a breath exhaust (25). A limited to, a nanoporous material, a microporous material, a 
fluid concentrator (23) opens into the interior chamber (27) chemically reactive material, a nonporous material and 
and is in flow communication (28) with the breath exhaust combinations thereof. Such absorbents include, for example, 
(25). In this embodiment, the breath is circulated through the activated carbon, silica gel, activated alumina, molecular 
chamber using a fan (21). The sensor array (26) is in flow zs sieve carbon, molecular sieve zeolites, silicalite, AlPO,, a 
communication with the desorbed analyte. 
In various embodiments, the fluid concentrator can be 
disposed within the sample chamber or outside the sample 
chamber. In addition, the sensor array can be disposed 
within the sample chamber or outside the sample chamber. 
Moreover, the sensor array can be configured to be external 
from the BCC and to extend into the mouth. or nasal cavity. 
The present invention embodies all such variations. 
Although the device of FIG. 1 is shown as a handheld 
breath collector and concentrator. those of skill in the art will 
polymer, a co-polymer, alumina and mixtures thereof In 
certain embodiments, the absorbent has a pore size from 
about 1 nm to about 100 nm and, preferably, from about 1 
nm to about 50 nm. 
Suitable commercially available adsorbent materials are 
disclosed in U.S. Patent Application Ser. No. 091271,873, 
filed Mar. 18, 1999, and include, but are not limited to, 
Tenax TA, Tenax GR, Carbotrap, Carbopack B and C, 
Carbotrap C, Carboxen, Carbosieve SIII, Porapak, 
35 Saherocarb. and combinations thereof Preferred adsorbent 
30 
appreciate that in certain other embodiments, the device and combinations include, but are not limited to, Tenax GR and 
methods of the present invention can be adapted and con- Carbopack B; Carbopack B and Carbosieve SIII; and Car- 
figured to detect within or around various other areas of bopack C and Carbopack B and Carbosieve SI11 or Car- 
interest including, but not limited to, mucous membranes, boxen 1000. Those skilled in the art will know of other 
nose, nasal passages, eye, skin, ear, inner ear, mouth, tongue, 40 suitable absorbent materials. 
throat, colon, duodenum, body cavities, stomach, vagina and After sometime period that is chosen to be adequate for 
penis. Moreover, the device and methods of the present sorbing the desired analytes from the vapor phase onto the 
invention can be configured to detect all body fluids material, the circulation is stopped and then the material is 
including, but not limited to, urine, perspiration, tears, desorbed from the sorbent phase and released into the sensor 
blood, mucus, pus, salvia, feces, menstruation fluid, sperm, 45 chamber. The desorbing of the concentrated analyte for the 
eggs, spinal fluid and mammary gland discharge. sorbent can be by accomplished by thermal means, mechani- 
In another embodiment, the sample chamber is a head cal means or a combination thereof Desorption methods 
space analyzer (HSA) and can be fabricated from an inert include, but are not limited to, heating, purging, stripping, 
material, such as a molded fiberglass, or in certain embodi- pressuring or a combination thereof. 
ments can be fabricated from plastic and can be configured SO In certain embodiments, the sample concentrator is 
like a box. As illustrated in FIG. 3, the sample chamber (32) wrapped with a wire through which current can be applied 
optionally has a glass-viewing window and the box can to heat and thus, desorb the concentrated analyte. The 
contain pressure and temperature gauges (37) to allow analyte is thereafter transferred to the sensor array. 
pressure and temperature monitoring. Moreover, the sample The process of sorbing the material onto the sorbent phase 
chamber optionally contains valves for gas input and ss not only can be used to concentrate the material, but also can 
exhaust of the box. Optionally, the sample chamber com- be advantageously used to remove water vapor. The water 
prises a heater and a pressure control means for an internally vapor is preferably removed prior to concentrating the 
controlled atmosphere. analyte; however, in various embodiments, the vapor can be 
Similar to the BCC, the HSA has a first end (34) that is removed concomitantly or after the analyte is concentrated. 
open for access to the interior chamber (32) and functions as 60 In a preferred embodiment, the water vapor is removed prior 
an inlet port (30) and is vented by an exhaust (35). A fluid to presenting the desired analyte gas mixture to the sensor 
concentrator (33) is disposed outside the sample chamber array. Thus, in certain embodiments, the fluid concentrator 
and is in flow communication (36) with the exhaust (35). contains additional absorbent material to not only concen- 
The sensor array (39) is in flow communication with the trate the analyte, but to remove unwanted materials such gas 
desorbed analyte. 
Optionally, the HSA contains appropriate connections for In certain instances and depending on the absorbent used, 
high throughput screening (HTS). High throughput screen- the concentration factor can exceed a factor of lo5, and more 
65 contaminates and moisture. 
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preferably by a factor of about 10’ to about lo4. Thus, the sensing the presence of an analyte in a fluid with a chemical 
analyte gases can be concentrated from an initial sample sensor comprising first and second conductive leads electri- 
volume of about 10 liters and then desorbed into a volume cally coupled to and separated by a chemically sensitive 
of about 10 milliliters or less when they are presented to the sensor as described above by measuring a first response 
sensor array. 5 between the conductive leads when the sensor is contacted 
The array of sensors is present in fluid communication with a first fluid comprising an analyte at a first concentra- 
with the concentrated analyte. Various sensors suitable for tion and a second different response when the sensor is 
detection of analytes include, but are not limited to: surface contacted with a second fluid comprising the analyte at a 
acoustic wave (SAW) sensors; quartz microbalance sensors; second different concentration. As discussed above, suitable 
conductive composites, chemiresitors; metal oxide gas responses include, but are not limited to, resistance, 
sensors, such as tin oxide gas sensors; organic gas sensors; impedance, capacitance, inductance, magnetic, optical, etc. 
11. Medical Applications metal oxide field effect transistor (MOSFET); piezoelectric devices; infrared sensors, temperature sensors, humidity 
sensors, sintered metal oxide sensors; Pd-gate MOSFET; The methods and apparatus of the Present invention are 
metal FETstructures; metal oxide sensors, such as a Tuguchi extremely useful and can be advantageouslY used for the 
gas sensors; phthalocyanine sensors; e~ectrochemica~ cells; 15 detection, identification, and classification of trace gas 
conducting polymer sensors; catalytic gas sensors; organic components, and are extremely useful in a variety of 
semiconducting gas sensors; solid electrolyte gas sensors; applications, including medical applications. In certain 
piezoelectric quartz crystal sensors; dye-impregnated poly- aspects, the methods and devices of the present invention are 
mer films on fiber optic detectors; polymer-coated micro- useful and very effective for the detection and diagnosis of 
mirrors; electrochemical gas detectors; chemically sensitive 20 diseases. In general, certain volatile marker gas(es) charac- 
field-effect transistors; carbon black-polymer composite terizes the detection or diagnosis of a disease state or 
chemiresistors; micro-electromechanical system devices; medical condition. The methods and apparatus of the present 
and micro-opto-electro-mechanical system devices and invention can advantageously by used to detect volatile 
Langmuir-Blodgett film sensors. marker gases and compounds indicative of medical 
In a preferred embodiment, the sensors used in the present zs conditions, disease processes, infections, illness and well- 
invention are disclosed in U.S. Pat. No. 5,571,401, which is being. Using these marker gases and compounds, clinicians 
incorporated herein by reference. Briefly, the sensors can use the diagnostic instruments and methods of the 
described therein are conducting materials and nonconduct- present invention to make diagnoses and formulate appro- 
ing materials arranged in a matrix of conducting and non- priate treatments. The methods as described can optionally 
conducting regions. The nonconductive material can be a 30 be performed using a fluid concentrator as described herein. 
nonconducting polymer such as polystyrene. The conductive A. Oral infections 
material can be a conducting polymer, carbon black, an In certain aspects, the present invention is extremely 
inorganic conductor and the like. The sensor arrays comprise useful for the detection of infections, such as oral infections 
at least two sensors, typically about 32 sensors, and in and dental cares. For example, bacteria cause two wide- 
certain instances 1000 or more sensors up to about lo6 35 spread dental problems halitosis and periodontal disease 
sensors. In a preferred embodiment, at least two sensors are and,: as disclosed herein, the methods and apparatus of the 
compositionally different. The array of sensors can be present invention can detect the off-gases produced by such 
formed on an integrated circuit using semiconductor tech- bacteria. 
nology methods, an example of which is disclosed in PCT 1. Halitosis 
Patent Publication No. WO99108105, entitled “Techniques 40 Halitosis is caused by the breakdown of proteins by 
and Systems for Analyte Detection,” published Feb. 19, microbes on the back of the tongue. The tongue coating is 
1999, and incorporate herein by reference. Another preferred comprised of epithelial cells from the oral mucosa, leuko- 
sensor system is disclosed in PCT Patent Publication No. cytes from periodontal pockets, and microorganisms. While 
WO99127357, published Jun. 6, 1999. the mouth is resident to over 300 bacterial species (see, 
In certain embodiments, the temporal response of each 45 Loesche et al., In Rosenberg M., Editor, “Bad Breath: 
sensor (response as a function of time) is recorded and can Research Perspectives,” Proceedings of the First Znterna- 
be displayed. Various responses include, but are not limited tional Workshop on Oral Malodor, Ramot Publishing, Tel 
to, resistance, impedance, capacitance, inductance, Aviv University pp. 41-54 (1993)), the relative size of each 
magnetic, optical, etc. The temporal response of each sensor population is a function of many factors. Bad breath has 
can be normalized to a maximum percent increase and SO been associated with the expansion of anaerobic species 
percent decrease that produces a response pattern associated (see, Loesche et al., In Rosenberg Ed., “Bad Breath: 
with the exposure of the analyte. By iterative profiling of Research Perspectives,” Proceedings of the First Znterna- 
known analytes, a structure-function database correlating tional Workshop on Oral Malodor, Ramot Publishing, Tel 
analytes and response profiles is generated. Unknown ana- Aviv University pp. 41-54 (1993); de Boveri HE et al., J .  
lytes can then be characterized or identified using response ss Am. Dent. Assoc., 126:1384-1393 (1995)). The underlying 
pattern comparison and recognition algorithms. cause of the increase in anaerobes can be poor oral hygiene, 
Accordingly, analyte detection systems comprising sensor aging, deep crevices in the tongue, post-nasal drip, or 
arrays, a measuring device for detecting responses across numerous other conditions. 
each sensor, a computer, a display, a data structure of sensor The chemical markers of bad breath have been identified 
array response profiles, and a comparison algorithm(s) or 60 and include, but 30 are not limited to, volatile sulfur com- 
comparison tables are provided. In another embodiment, the pounds (VSC) (see, Richter et a1,Arch. Oral Biol., 9:47-53. 
electrical measuring device or detector is an integrated (1964); Tonzetich, Arch. Oral Biol., 16:587-597 (1971); 
circuit comprising neural network-based hardware and a Tonzetich, J .  Periodontol. 48: 13-20 (1977); Tonztich J, J .  
digital-analog converter (DAC) multiplexed to each sensor, Znt. Dent. J .  28:309-319 (1978); and Tonzetich, Arch. Oral 
or a plurality of DACs, each connected to different sensor(s). 65 Biol., 16:587-597 (1971)). 
In certain embodiments, a method for using the sensors As such, the present invention provides a method for the 
for detecting the presence of an analyte in a fluid involves detection of halitosis, the method comprising: contacting an 
10 . 
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array of sensors with mammalian breath suspected of con- 
taining a marker gas indicative of halitosis; and detecting the 
marker gas to determine the presence of halitosis. In pre- 
fared embodiments, the marker gases being detected by the 
sensors are volatile sulfur compounds. 
C. Wound healing 
One of the major reasons for slow healing wounds can be 
a high level of bacteria. Frequently, wound healing is largely 
undetected due to lack of tests for detecting microorganisms. 
s Slow wound healing is a problem that effects more than a 
million people each year and costs billions of dollars to treat. 
assessment is to smell the on the dressing, Nurses 
are advised to be aware of a “repulsive,, odor that may be 
i o  associated with necrotic tissue and “acrid or putrid” smells 
that are’ associated with anaerobic bacteria’ 
these methods suffer from lack Of specificity. 
While the absence of odor is indicative of a clean wound, the 
presence of odor does not necessarily signal an infection The 
to elicit an inflammatory 15 switch in recent years to moisture-retaining “wet dressings” 
has further complicated the Problem of wound assessment. 
is due entirely to the materials in the dressings. 
2. Periodontal Disease 
A far more serious consequence of oral infections is Unfortunately, one of the standard techniques of wound 
periodontal disease. Gingivitis is the inflammation of the 
gums and periodontitis is when the gum infection damages 
the bone and supporting tissues. These conditions are the 
result of the expansion of certain species of bacteria. If a 
piece of food is trapped between the teeth, the bacterial types 
that can utilize the various nutrients present will multiply. In. 
addition, of their metabolic products can give rise to 
a second array of organisms, h d  finally, if the popu~ation 
exp~osion of bacteria is 
response, a third wave of bacteria can arise that prefers the 
Rosenberg, Bad Breath Research Perspectives, Ramot 
Publishing, Tel Aviv, pp. 41-54 (1993)). While there is a quantitative culture methodology that can 
VSC are also an indicator of periodontal disease (see, 20 be employed to eliminate human errors, it is very expensive 
Loesche et al., In Rosenberg, Bad Breath: Research and time consumingh such, it is only used routinely in burn 
Perspectives, Ramat Publishing, Tel Aviv, (1995); Yaegaki et centers where patients are in much more serious conditions. 
al., J .  Periodontia. Res. 27:233-238 (1992); Tonzetich et al., Advantageously, the present invention provides a method 
J .  Dent. Res 58:175 (1979); Frostell et al., Dent. J .  for diagnosing wound healing comprising: contacting the 
20:436-450 (1970), Sat0 et al., Bull. Tokyo Dent. Coll., zs vapors associated with the wound with an array of sensors, 
21:171-178 (1980); Kostelc et al., J .  Periodontal Res. thereby assessing the wound healing process. 
15:185-192 (1980)). In addition, a number of other com- D. Vaginitis 
pounds can be indicative of various bacterial populations The vaginal discharge of women with bacterial vaginitis 
(see, Bosy et al., J .  Periodontal 65:37-46 (1994); McCul- often has a prominent fishy odor. The presence of 
loch et al., In Rosenberg, BadBreath Research Perspectives, 30 methylamine, isobutylamine, putrescine, cadaverine, 
Ramat Publishing, Tel Aviv, pp. 109-117 (1995)). histamine, tyramine, and phenethylamine are marker gases 
Asignificant development in recent years has been the use of vaginitis (see, Brand et al., Obstetrics and Gynecology, 
of anti-microbials to treat periodontitis instead of surgery. It 68, 682-685 (1985)). Thus, the present invention provides a 
has been shown that 80% of patients scheduled for surgery method for the detection of vaginitis, the method compris- 
or extractions could be successfully treated with a course of 35 ing: contacting an array of sensors with vaginal vapors or 
metronidazole, doxycycline, or chlorhecidine. Overall, only discharge suspected of containing a marker gas indicative of 
about 10% of the teeth required the conventional surgery or vaginitis; and detecting the marker gas to determine the 
extraction. Surprisingly, by using the apparatus of the presence of vaginitis. 
present invention, it is possible to make a quick diagnosis, E. Fertility 
thereby alleviating unnecessary surgery. In yet another aspect, the present invention provides 
As such, the methods and apparatus of the present inven- methods and apparatus for the detection of ovulation. The 
tion can be used for the detection of periodontal disease. fertile period of a female mammal, such as a human being, 
Thus, the present invention provides a method for the can be detected by. measuring axillary secretions. The 
detection of periodontal disease, the method comprising: markers are androstenol and/or dehydroepiandrosterone sul- 
contactinn an arrav of sensors with mammalian breath 45 fate. Thus. the aresent invention arovides a method for 
gingival crevicular fluid (see, Loesche w J et at, In Most dressings have strong odors, but often times the odor 
40 
v 
suspected of containing a marker gas indicative of periodon- 
tal disease; and detecting the marker gas to determine the 
presence of periodontal disease. As explained above, and 
detailed hereinbelow, numerous marker gases can be used to 
detect and evaluate the severity of periodontal disease. 
B. Pneumonia Detection 
In certain instances, it currently takes two to three days to 
culture the bacteria and determine whether the species that 
cause pneumonia are present. Often, rather than waiting for 
this determination, medical personnel prescribe broad- 
spectrum antibiotics. Unfortunately, this prophylactic pro- 
detecting ovulation, the method comprising: contacting an 
array of sensors with vaginal vapor for the presence of a 
marker gas indicative of ovulation; and detecting the marker 
gas to determine ovulation. 
SO F. Other Applications 
In addition to the foregoing applications, other applica- 
tions for the methods and devices of the present invention 
include, but are not limited to, environmental toxicology, 
remediation, biomedicine, material quality control, food 
ss monitoring, agricultural monitoring, heavy industrial 
manufacturing, ambient air monitoring, worker protection, 
cedure can promote the emergence of antibiotic-resistant emissions control, product quality testing, oiligas petro- 
strains . chemical applications, combustible gas detection, H,S 
The methods and devices of the present invention can monitoring, hazardous leak detection, emergency response 
alleviate the unnecessary prescribing of antibiotic(s) by 60 and law enforcement applications, explosives detection, 
providing rapid accurate detection and diagnosis of bacteria utility and power applications, foodlbeverageiagriculture 
attributable to pneumonia. Thus, the present invention pro- applications, freshness detection, fruit ripening control, fer- 
vides a method for the detection of pneumonia, the method mentation process monitoring and control, flavor composi- 
comprising: contacting an array of sensors with mammalian tion and identification, product quality and identification, 
breath suspected of containing a marker gases indicative of 65 refrigerant and fumigant detection, cosmeticiperfume 
pneumonia; and detecting the marker gas to determine the applications, fragrance formulation, chemicaliplasticsi 
presence of pneumonia. pharmaceut icals  appl icat ions,  fugi t ive emission 
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identification, solvent recovery effectiveness, hospital1 
medical applications, anesthesia and sterilization gas 
detection, infectious disease detection, breath analysis and 
body fluids analysis. 
gens are set forth in 
picolines (see, Kostelc et al., J .  Periodont. Res., 15:185-192 
(1981); Kostelc et clin, Chem,, 27:842-845 (1981)). 
Overall, more than 80 volatile compounds have been shown 
etal., J .  High Resol. Chromatogr., 20:94-98 (1997)) and the 
Various other medical conditions and associated patho- 5 to be a~sociated with saliva or tongue scrapings (see, Claus 
TABLE 1 
INFECTIONS AND PATHOGENS 
Infection Pathogen Area of Interest 
Acute Sinusitis 
Pharyngitis 
Pneumonia 
Bronchitis 
American Thoracic 
Society (ATS) Class 111 CAP 
Severe CAP 
ATS Class IV-ICU 
Cystitis in females; 
Pyelonephritis; Prostatitis or 
Epididymoorchitis 
Acute Meningitis 
Meningitis(post surgical); 
Brain abscess 
Biliary tract; Peritonitis or 
Diverticular abscess 
Cellulitis; Lymphangitis 
Cat bite, Dog bite, Decubitus 
ulcers, (uncomplicated) or 
Diabetic foot ulcer 
(uncomplicated); Toxic Shock 
EndometritisIEndomyometritis 
Pelvic Inflammatory Disease; 
Septic Thrombophlebitis 
(postpartum) 
Endocarditis (IE) 
Prosthetic valve 
Septic arthritis, Prosthetic 
joint, Osteomyelitis 
Strep. pneumoniae, H. flu, 
Moraxella catarrhalis, Group 
A strep., G(+) anaerobes, 
Staph. aureus 
Group A,C,G strep. 
Strep. pneumoniae, 
Mycoplasma, Chlamydia 
pneumoniae, H. flu 
Strep. pneumoniae, H. Flu, 
Moraxella 
Strep. pneumoniae, H. 
influenzae, Klebsiella, Staph. 
aurew, Legionella Sp., 
Pseudomonas aerug., 
other gram-negative bacteria; 
Strep. pneumoniae, Staph. 
aurew, Legionella Sp., 
Pseudomonas aerug., other 
gram negative bacteria 
Enterobacteriaceae; 
Enterobacteriaceae & 
Enterococcus sp. 
Hemophilus influenzae, 
Pneumococci, N .  meningitidis 
Staphylococcus sp., gram- 
negative bacteria; 
Streptococcus sp., anaerobes, 
Staph. sp. 
Enterobacteriaceae, 
Enterococcus sp., anaerobes 
Streptococcus sp., 
Staphylococcus sp.; Pasturella 
multicida, Staph & Strep., 
anaerobes, Gram negative 
bacteria; Gram-positive 
bacteria; Anaerobes 
Enterobacteriaceae, 
Chiamydia sp., Streptococcus 
sp. (group B Streptococcus), 
Neiserria gonorrhoeae 
Streptococci sp. 
Staphylococcus sp. 
Staphylococcus epi. 
Staphylococcus sp. & Strep. 
sp., Neisseria gonorrhoeae, 
Staphylococcus sp., 
Staphylococcus sp., Staph & 
Strepsp., Enterobacteriaceae, 
anaerobes 
Sinus 
Pharynx 
Lungs 
Lungs 
Lung 
Urinary Tract 
CNS 
Abdomen 
Skin 
Pelvis 
Heart 
Bone & Joint 
G. Markers ss methods and apparatus of the present invention can be used 
As explained above, volatile sulfur compounds (e.& H,S, to advantageously detect such marker compounds and gases. 
CH3SH, CH3S-cH3) are the marker gases implicated Using the methods and apparatus of the present invention 
in halitosis and periodontal diseases (see, Tonzetich, Arch. it is also possible to detect the off-gasses associated with 
5:233-236 (1967)). Other analytes that have been shown to correlate with such clinical findings include, but are not 60 limited to, Prevotella intermedia; Fusobacterium nuclea- 
limited to, volatile organic acids (VOA), indolelskatole turn; Porphyromonas gingivalis; Porphyromonas endodon- 
(indole), and diamines (see, Goldberg et J ,  Dent, R ~ ~ , ,  talis; Prevotella loescheii; Hemophilusparainfuenzae; Sto- 
73:1168-1172 (1994); Goldberg et al., In Rosesberg M Bad ~~~~~~~~~~ muci; Treponema denticola; Veillonella 
Breath Research Perspectives, Ramat Publishing, Tel Aviv, species; Peptostreptococcus anaerobius; Micros Prevotii; 
pp. 71-85 (1995)). 65 Eubacterium limosum; Centipeda periodonti; Selemonad 
In addition, several other analytes have been reported to aremidis; Eubacterium species; Bacteriodes species; Fuso- 
be associated with oral infections including pyridines1 bacterium periodonticum; Prevotella melaninogenica; 
Oral Bioi, 16:587-597 (1971); Rizzo, Periodontics, bacteria associated with oral maladies including, but not 
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Klebsiella pneumoniae; Entevobactev cloacae; Citrobacter 
species and Stomatococcus mucilaginus. 
Moreover, a wide variety of analytes and fluids can be 
detected and analyzed using the disclosed sensors arrays and 
electronic noses so long as the subject analyte(s) and fluids 
are capable of generating a differential response across a 
plurality of sensors of the array. Analyte applications include 
broad ranges of chemical classes including, but not limited 
to, organics such as alkanes, alkenes, alkynes, dienes, ali- 
cyclic hydrocarbons, arenes, alcohols, ethers, ketones, 
aldehydes, carbonyls, carbanions, polynuclear aromatics 
and derivatives of such organics, e.g., halide derivatives, 
etc.; biomolecules such as sugars, isoprenes and isoprenoids; 
VOC; VOA; indoles; skatoles; diamines; pyridines; 
picolines; fatty acids; and derivatives of the forgoing, etc. 
In addition to breath, the sensor arrays of the present 
invention can be used o identify various analytes in other 
biological fluids. These fluids include, but are not limited to, 
urine, perspiration, tears, blood, mucus, pus, salvia, feces, 
menstruation fluid, sperm, eggs, spinal fluid and mammary 
gland discharge. 
In general, most conditions and diseases listed herein 
have microorganisms associated with them. The presence of 
marker gases and compounds associated with the microor- 
ganism is in turn, indicative of the presence of the disease or 
condition. In a preferred embodiment, the off-gas of the 
microorganism is the marker that is detected by methods and 
devices of the present invention. 
111. ANESTHETICS 
In certain anesthetic vaporizers, a carrier gas, such as air, 
oxygen or nitrous oxide, is divided between a first stream 
directed to a chamber, wherein an anesthetic liquid is 
resident and a second stream or bypass stream. The first and 
second streams are recombined before delivery to the 
patient. Another version of an anesthetic vaporizer is 
embodied in a device wherein the anesthetic agent is 
injected directly into the carrier gas stream. 
In either instance, it is imperative that the concentration of 
volatile anesthetic liquid be known. The present invention 
provides methods and an apparatus for the process control of 
anesthetic gases. Using the methods and apparatus of the 
present invention, a fluid concentrator is optionally used 
when monitoring and quantitating anesthetic concentration. 
By using the apparatus and sensors described herein, it is 
possible to detect and quantitate the concentration of volatile 
anesthetics including, but not limited to, halothane, 
isoflurane, servoflurane, desflurane and enflurane. As such, 
the present invention provides an anesthetic vaporizing 
system for quantitating the concentration of the anesthetic, 
comprising: a carrier gas source for delivering a carrier gas 
stream to a bypass valve, wherein the bypass valve splits the 
carrier gas stream into a first carrier gas stream for delivery 
to an inlet port and a second carrier gas stream for delivery 
to a joining valve; 
a vaporizing chamber for an anesthetic agent, comprising 
the inlet port, an outlet port, a vaporizing means and a 
conduit for delivery of vaporized anesthetic from the 
outlet port to the joining valve; and 
an array of sensors in flow communication with the 
joining valve to quantitate the anesthetic. In preferred 
embodiments, the system further comprising a detector 
operatively associated with each sensor that provides a 
response in the presence of an anesthetic vapor. 
With reference to FIG. 4, the carrier gas source (41) 
delivers the carrier gas to a bypass valve (44), wherein the 
S 
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carrier gas is split between a first carrier gas stream for 
delivery to the inlet port (45) of the anesthetic vaporizer (40) 
and a second carrier gas stream which connects to a joining 
valve (46). The anesthetic vaporizer contains a vaporizing 
means, such as a heater, pressure souce or aspirator (48). The 
vaporizer includes an outlet port (42) for delivery of the 
vaporized anesthetic through a conduit (43) to the joining 
valve. The sensor array (49) is in flow communication with 
the joining valve. 
The present invention also provides a method of quanti- 
tating an anesthetic vapor, comprising: containing the anes- 
thetic vapor with a sensor array to produce a response; 
detecting the response with a detector, thereby quantitating 
the anesthetic vapor. 
The following examples are meant to illustrate and not 
limit the present invention. 
IV. EXAMPLES 
Example 1 
In this Example, the detection and identification of bac- 
teria was conducted by measuring the metabolic products 
produced from plate bacteria cultures carried out using an 
electronic nose (a 32-sensor array) and a Fisher Linear 
Discrimination (FLD) algorithm. 
As shown herein, the data was also examined using 
principal component analysis (PCA) and statistical isolinear 
multicategory analysis (SIMCA). The results carried out on 
two very distinct bacteria, i. e., peptostveptococcus anevo- 
bius and povphyvomonas gingivalis, show that the two 
bacteria were clearly discriminated by the sensors as shown 
by PCA. The metabolites of additional an 11 bacteria and 
one fungus plus controls were tested and the data was 
examined using PCA, SIMCA and FLD and discrimination 
among the bacteria was demonstrated. 
The objective of these experiments was to evaluate the 
discriminating capability of a thirty-two sensor array com- 
posed of mixtures of polymers and carbon black for metabo- 
lites produced by a variety of bacteria. Fourteen fresh 
cultures were tested for the 20 most commonly suspected 
malodor producing, oral and pharyngeal anaerobic and fac- 
ultative bacteria including a fungus using a 32-sensor array. 
The experiment was done in two phases. The first phase 
consisted of testing two very distinct bacteria, peptostvep- 
tococcus anevobius and povphyvomonas gingivalis, plus a 
control (the media in which the bacteria were independently 
grown). Four sample tubes of each bacterium and the control 
were tested to investigate reproducibility. The results from 
the first test indicated that gingivalis and anevobius could be 
discriminated from each other and the control using a sensor 
array discussed herein. 
Ten samples of eleven bacteria, a fungus and ten controls 
were tested with the same sensor array used described 
above. Table 3 lists the bacteria plus the main metabolite 
known to be produced by these bacteria. Various statistical 
and mathematical techniques were used to analyze the data 
obtained with chemiresistors on these microorganisms. One 
of the methods used to classify the metabolites produced 
from the various bacteria was principal component analysis, 
an unsupervised pattern recognition technique. PCA trans- 
forms multidimensional data sets into a lower dimensional 
graphical representation, which describes a majority of the 
variation in a data set. PCAdefines a new set of axes to plot 
the samples, they are constructed so that a maximum amount 
of variation is described with a minimum number of axes, 
and the data is hence readily visualized in this transformed 
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data space (see, K. R. Beebe, R. J. Pell, M. B. Seasholtz, FIG. 5 .  Note that the reproducibility of the sensor array was 
Chernornetrics: A Practical Guide, Wiley, New York, 1998) very good. The response (the normalized resistance change, 
Another algorithm used to analyze the data set was Fisher (Rmaz-R,)/RO), where R, and R, are the maximum and 
Linear Discrimination (FLD). FLD seeks a linear combina- base (initial) resistance, respectively) of the Sensor array to 
tion of the variables, which maximizes the ratio of its 5 each sample tested is employed to form a covariance matrix, 
between-group variance to its within-group variance (see, B. which is used to do principal component analysis, PCA of 
D. Ripley, Recognition and Uni- the two bacteria plus control (data not shown) were clearly 
versity Press, Cambridge, 1996, Chapter 3, p 93). discriminated by the sensor array. SIMCA was also used to Other algorithms used to analyze the data were K-nearest 
neighbor (KNN) and statistical isolinear multicategory evaluate the data. The model was built with all the data as 
analysis, SIMCA, ~~~h of these algorithms are supervised 10 the training set and the data from the first test was used as 
pattern recognition methods used for predicting the class of the ~ ~ k n o w n .  A ClasSification rate of 100% was obtained 
unknown samples given a training set of samples with using the SIMCA algorithm. KNN was also used to examine 
known class membership. With KNN, a classification is the. data set. A model was built using the data from three 
always made, whether or not the unknown is a member of sample tubes of each bacteria plus the control. One of the 
the class in the training set. KNN is a much simpler IS samples was used as the unknown. Using 3 or 5 nearest 
algorithm than SIMCAbecause unlike SIMCAit makes no neighbors in the KNN algorithm gave a classification rate of 
assumptions about the size or shape of the class. SIMCAcan 66%. The FLD algorithm was not used on this data set, 
detect if an unknown sample is not a member of any class 
in the training set, SIMCAuses the shape and position ofthe 
object formed by the samples in a class for class definition 
In the second phase study, ten Of l1 bacteria and 
One fungus were tested. The temperature Of the substrates 
(see, K, R, Beebe, R, J, pell, M, B, Seasholtz, (-hernornet- 20 was controlled at 2820.1" C. for all tests. The sample tubes 
rics, .~ practical Guide, wiiey, New york, 1998). The were not temperatures controlled. As described in the experi- 
obtained using all the described algorithms are set forth mental section, each bacterium was tested 19 times among 
below. 9 test tubes. Thirty-two sensors responded to bacteria and 
A. EXPERIMENTAL one fungus, 19 times for each. A covariance matrix that 
1. Testing Protocol 25 contained 32 columns (one column for each sensor 
Thirty polymers were chosen based both on structural response) and 12x19 rows (bacteria tested at different times) 
differences and on solubility to generate a thirty two sensor was formed. This matrix was used to do principal compo- 
array. The testing protocol used for all the bacteria was the nent analysis. 
same and is described below. Anerobius and gingivalis were A different algorithm, ~ i ~ h ~ ~  ~i~ ~~ i ~ ~ ~ i ~ i ~ ~ ~ i ~ ~ ,  was 
tested in one day, whereas the rest of the bacteria were tested 30 introduced to process the data set, To construct a model 
using the FLD method, it is required that the data take the over several days. Testing instrument: A Keithley electrometer and scanner form of a square matrix, The columns and rows in the matrix were used to scan the resistances of 32 sensors during the correspond to the number of sensors and the number of test experiment. 
using nitrogen gas as the carrier. The flow rate used was 100 needs to be to the number Of tests. 
mL/minute, N~ dilution with air was done, The flow rate of Each of the 11 bacteria and one fungus were tested 19 times 
the background air used to purge the Sensors was 10 thus, only 19 sensors could be used to construct the FLD 
L/minute. No preconcentration was preformed. model. Hence, a square matrix was formed using each of the 
Temperature: The temperature of the substrates was not bacteria tested 19 times and choosing 19 sensors out of the 
controlled and the measurements were done at room tem- 40 32. The very first test (tube 1) and the last test (tube 5) of 
perature for the first phase study. The temperature of the each bacterium were used as ~ ~ k ~ o w n s .  The first 19 S e m m  
substrates was maintained at 2821" C. for the second phase out of the 32-sensor array were found to give the highest 
study. prediction rate out of other sensor combinations. Twenty- 
Purge and Exposure times: For each sample test, there four ~ ~ k n o w n s  were Predicted from the FLD model. The 
120 seconds of exposure time, 120 seconds of recovery time T. D., Presser, o., Hulbert, J. N., Marshall, R. w.,  Corcoran, 
(purged with air with RH level of about 3%), 180 seconds of p., Lowery, p., Ruck-Keene, E. A., Heron, s., &mors and 
recovery without recording the data (purged with air), and Actuators (B) 44, 413422,  1997). 
30 seconds of final recording time (purged with air). As a comparison, a SIMCAmodel was built with the same 
B. RESULTS AND DISCUSSION 50 training set used for the FLD analysis. The same 24 
unknowns was used for SIMCA prediction. The results 
provided a classification rate of 75%. The KKN algorithm 
was also used and the classification rate was 66%. 
Sampling: the headspace above the bacteria was sampled 35 Hence, to FLD, the number Of 
were 60 seconds of background recording (purged with air), 45 results provided a classification rate of 91.7% (see, Gibson, 
1. Sensor Array Response 
The response pattern of the 32-sensor array described 
above to anerobius, gingivalis, and the control is shown in 
TABLE 2 
SENSOR COMPOSITION AND DEPOSITION CONDITIONS 
P'er # Polymer 
Sensor Dilution 
# Solvent Ratio 
CHIP EM-1-070798 
19 Hydroxypropyl cellulose Sr 1 water 150 to 1 
22 Methyl vinyl ether-co-maleic acid, 50150 Sr 2 water 151 to 1 
34 Polyacrylamide Sr 3 water 150 to 1 
35 Polyacrylamide, carboxyl modified (LC) Sr 4 water 150 to 1 
36 Polyacrylamide, carboxyl modified (HG) Sr 5 water 150 to 1 
17 
TABLE 2-continued 
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SENSOR COMPOSITION AND DEPOSITION CONDITIONS 
Sensor Dilution 
P’er # Polymer # Solvent Ratio 
5s 
73 
74 
3 
10 
12 
39 
42 
41 
48 
so 
54 
59 
63 
68 
80 
87 
9 s  
79 
63 
79 
86 
82 
90 
104 
10s 
102 
Poly(ethy1ene oxide) 
Poly(viny1 alcohol), 100% hydrolyzed 
Poly(viny1 alcohol), 98% hydrolyzed 
CHIP EM-2-070798 
Alginic acid, sodium salt 
Ethylene-co-ethyl acrylate, 82/18 
Ethylene-co-vinyl acetate, 86/14 
1,2-Polybutadiene 
Polycaprolactone 
Poly(n-butyl methacrylate) 
Poly(n-ethyl methacrylate) 
Polyethylene, chlorinated (42& Cl) 
CHIP EM-3-070798 
Polyethylene, chlorosulfonated 
Poly(isobuty1 methacrylate) 
Poly(a-methyl styrene) 
Polystyrene 
Poly(viny1 stearate) 
Styrenelethylenebutylene, ABA block 
Vinyl chloridelvinyl 
acetatelhydroxyprop yl 
Poly(viny1 pyrrolidone) 
CHIP EM-4-070798 
Poly(a-methyl styrene) 
Poly(viny1 pyrrolidone) 
Styrene-co-butyl methacrylate 
Styrene-co-acrylonitryle, 75/25 
Vinyl alcohol-co-vinyl butyral; 20180 
Poly (4-methoxy styrene) 
Poly methyl hydrosiloxane 
Poly diphenoxyphosphazene 
Sr 6 
Sr 7 
Sr 8 
Sr 9 
Sr 10 
Sr 11 
Sr 12 
Sr 13  
Sr 14 
Sr 15 
Sr 16 
Sr 17  
Sr 18 
Sr 19 
Sr 20 
Sr 21 
Sr 22 
Sr 23 
Sr 24 
Sr 25 
Sr 26 
Sr 27 
Sr 28 
Sr 29 
Sr 30 
Sr 31 
Sr 32 
water 
water 
water 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
toluene 
water 
toluene 
water 
toluene 
THF 
THF 
THF 
THF 
THF 
150 to 1 
150 to 1 
150 to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
2s to 1 
150 to 1 
2s to 1 
150 to 1 
2s to 1 
100 to 1 
100 to 1 
100 to 1 
100 to 1 
100 to 1 
carbon black was used in each sensor at a concentration between 20-25 wt % 
TABLE 3 
LIST OF BACTERIA AND THEIR METABOLIC PRODUCTS 
BACTERIA NOMENCLATURE METABOLIC PRODUCTS OR OFF-GASES 
Enterobacter cloacae 
Cit. Koseri 
Psuedomonas Aeruginosa 
Veilonella species 
Prevotella melaninogenica 
Escherichia coli 
Kiebseilla Pneumoniae 
Streptococcus mutans 
*Candida albicans 
Prevotella intermedia 
Fusobacterium nucleatum 
Staph. aureus 
Peptostreptococcus anerobius 
Porphyromonas gingivalis 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
Bac 
8 
9 
10 
11 
12 
Isobutyric and isovaleric acid 
NIA 
NIA 
Acetic and propionic acid and 
isoamyl alcohol 
Isovaleric acid 
Acetic and propionic acid 
Methyl ethyl ketone, methylbutanal, 
2-butanol, pentanone, dimethyl sulfide, 
isobutanol, isopentylacetate, 2-heptanone 
isopentanol, 2-nonanone, 2-undecanone 
Acetic acid, propionic acid 
NIA 
Isovaleric acid 
Acetic, propionic and butyric acid 
Acetic, 2-butanone, 2-butanol, pentanone, 
methyl butanol, toluene, 2-heptanone, 
isopentanol, 2-nonanone, 2-undecanone, 
acetone, 2-nondecagon 
Acetic, isobutyric, butyric, 
isovaleric and isocaproic acid 
Isovaleric acid 
*This is a fungus 
Example 2 
comprising the sensor arrays of the present invention are 
suitable for process control of anesthetic gases. As disclosed 
herein, a method for monitoring anesthetic gases in order to 
This Example illustrates that the apparatus and methods 65 establish reliable monitoring of a patient’s condition while 
under anesthetics is possible. Conducting-polymer compos- 
ite sensors change resistance when exposed to an analyte in 
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the vapor phase, and the pattern of such resistance changes from the group consisting of heating, purging, stripping, 
across an array allows identification of a concentration of an pressuring or a combination thereof. 
analyte. The pattern height allows identification of the 13. A device in accordance with claim 1, further com- 
concentration of an analYte. The experiments show that prising an additional adsorbent to remove unwanted material 
these arrays are suitable for process control over the con- 5 from said analyte fluid, 
centration of anesthetic gases at levels that are clinically of 14, A device in accordance with claim 13, wherein said 
interest. unwanted material is a gas contaminate. 
Using a 18-sensor array a suitable concentration of hal- 15. A device in accordance with claim 13, wherein said 
othane was delivered. The flow rate of the carbon dioxide unwanted material is moisture, 
carrier gas was 10 mlimin. The anesthetic gas flow rate was 16, A device in accordance with claim 1, wherein said 
o.2 mLimin2 thus the ratio Of carrier gas flow Over the response is an electrical response, and wherein said electri- 
summation Of the carrier gas flow and the anesthetic gas flow cal response is a member selected from the group consisting 
was 2%. FIG. 7 illustrates the response of 2% halothane on of electrical resistance, impedance and capacitance, 
the sensor array. FIG. 8 illustrates the linear response for 17, A device in accordance with claim 1, wherein said 
1s array of sensors comprises a member selected from the sensor 10 with halothane concentration. 
It is understood that the examples and embodiments group consisting of a surface acoustic wave sensor, a quartz 
described herein are for illustrative purposes only and that microbalance sensor; a conductive  composite^ a &emire& 
various modifications or changes in light thereof will be tor; a metal oxide gas and a conducting polymer 
suggested to persons skilled in the art and are to be included sensor, a dye-impregnated polymer film on fiber optic 
within the spirit and purview Of this 
the appended claims. d l  Publications, Patents, and Patent 
and scope Of 20 detector, a polymer-coated micromirror, an electrochemical 
gas detector, a chemically sensitive field-effect transistor, a 
applications cited herein are hereby incorporated by refer- 
ence for all purposes in their entirety. 
carbon b ~ a c k - p o ~ y m e r  compos~te ,  a micro-e~ec t ro-  
mechanical system device and a micro-opto-electro- 
mechanical system device. 
wherein said analyte is a microorganism marker gas indica- analyte is a member selected from the group consisting of 
tive of a respiratory tract infection, said device comprising: alkenes, alkynes, dienes, alicyclic hydrocarbons, 
a) a sample chamber having a fluid inlet Port for the influx arenes, alcohols, ethers, ketones, aldehydes, carbonyls, 
of said analyte; carbanions, polynuclear aromatics, heterocycles, organic 
b) a fluid concentrator in flow communication with said 30 derivatives, biomolecules, microorganisms, fingi, bacteria, 
sample chamber, said fluid concentrator having an microbes, viruses, metabolites, sugars, isoprenes and 
absorbent material capable of absorbing said analyte isoprenoids, fatty acids and their derivatives. 
and capable of desorbing a concentrated analyte; and 19. A device in accordance with claim 1, wherein said 
c) an array of sensors in fluid communication with said device is used in an application selected from the group 
concentrated analyte. 35 consisting of environmental toxicology, remediation, 
2. The device according to 1, claim further comprising a biomedicine, material quality control, food monitoring, agri- 
detector operatively associated with each sensor and pro- cultural monitoring, heavy industrial manufacturing, ambi- 
viding a response in the presence of said analyte. ent air monitoring, worker protection, emissions control, 
3. A device in accordance with claim 1, wherein said fluid product quality testing, oiligas petrochemical applications, 
concentrator is disposed within said sample chamber. 40 combustible gas detection, H,S monitoring, hazardous leak 
4. A device in accordance with claim 1, wherein said detection, emergency response and law enforcement 
sensor array is disposed within said sample chamber. applications, explosives detection, utility and power 
5. A device in accordance with claim 1, wherein said fluid applications, foodlbeverageiagriculture applications, fresh- 
concentrator and said sensor array are disposed within said ness detection, fruit ripening control, fermentation process 
sample chamber. 45 monitoring and control,  flavor composition and 
6. A device in accordance with claim 5, further compris- identification, product quality and identification, refrigerant 
ing a means to flow said analyte fluid from said inlet port to and fumigant detection, cosmeticiperfume applications, fra- 
said fluid concentrator and to said sensor array. grance formulation, chemicaliplasticsipharmaceuticals 
7. A device in accordance with claim 1, wherein said applications, fugitive emission identification, solvent recov- 
sample chamber comprises an internally controlled atmo- SO ery effectiveness, hospitalimedical applications, anesthesia 
sphere. and sterilization gas detection, infectious disease detection, 
8. A device in accordance with claim 1, wherein said breath analysis and body fluids analysis. 
absorbent material is a member selected from the group 20. A device in accordance with claim 1, further com- 
consisting of a nanoporous material, a microporous material, prising robotic armature for high throughput assay screen- 
a nonporous material and combinations thereof. 
9. A device in accordance with claim 8, wherein said 21. A device in accordance with claim 1, wherein said 
absorbent material is a member selected from the group array of sensors comprise about 10 to about 100 sensors. 
consisting of activated carbon, silica gel, activated alumina, 22. A device in accordance with claim 1, wherein said 
molecular sieve carbon, molecular sieve zeolites, silicalite, array of sensors comprise about 100 to about 1000 sensors. 
AIPO,, a polymer, a co-polymer, alumina and mixtures 60 23. A device in accordance with claim 1, wherein said 
thereof. array of sensors comprise about 1000 to about lo6 sensors. 
10. A device in accordance with claim 8, wherein said 24. A device in accordance with claim 1, wherein at least 
absorbent has a pore size from about 1 nm to about 100 nm. two sensors are compositionally different. 
11. A device in accordance with claim 10, wherein said 25. A device in accordance with claim 1, further com- 
absorbent has a pore size from about 1 nm to about 50 nm. 65 prising a computer, response profiles and an algorithm. 
12. A device in accordance with claim 1, wherein said 26. A device in accordance with claim 25, wherein said 
concentrated analyte is desorbed using a member selected 
What is claimed is: 
1. A device for detecting the presence Of an analyte, 25 18. A device in accordance with claim 1, wherein said 
ss ing. 
algorithm is a pattern recognition algorithm. 
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27. A device in accordance with claim 25, further com- 
28. A device in accordance with claim 1, wherein said 
device is a handheld device. 
29. The device in accordance with claim 1, wherein said 5 
respiratory tract infection is a lower respiratory tract infec- 
tion. 
30. The device in accordance with claim 1, wherein said 
respiratory tract infection is an upper respiratory tract infec- 
tion. 
31. The device in accordance with claim 29, wherein said 
lower respiratory tract infection is selected from pneumonia 
or bronchitis. 
32. The device in accordance with claim 30, wherein said 
upper respiratory tract infection is selected from sinusitis or 
pharyngitis. 
detecting an indicative marker gas, said device comprising: 
a) a sample chamber having a fluid inlet port for the influx 
40. A device for detecting bacterial vaginitis by detecting 
a) a sample chamber having a fluid inlet port for the influx 
of said indicative marker gas; 
b) a fluid concentrator in flow communication with said 
sample chamber, said fluid concentrator having an 
absorbent material capable of absorbing said indicative 
marker gas and capable of desorbing a concentrated 
c) an array of sensors in fluid communication with said 
41, The device in accordance with claim 40, wherein said 
1~ indicative marker gas is selected from the group consisting 
prising a neural network for software or hardware analysis. an indicative marker gas, said device comprising: 
10 indicative marker gas; and 
concentrated indicative marker gas. 
33, A device for detecting a respiratory tract infection by of methylamine, isobutylamine, putrescine, cadaverine, 
histamine, tyramine, and PhenethYlamine. 
42. A device for detecting the presence of an analyte, 
wherein said analyte is a microorganism marker gas indica- of said marker gas; 
b) a fluid concentrator in flow communication with said 20 tive of a urinary tract infection said device comprising: 
chamber, said fluid concentrator having an a sample chamber having a fluid inlet port for the influx absorbent material capable of absorbing said marker 
gas and capable of desorbing a concentrated marker 
gas; and 
c) an array of sensors in fluid communication with said 25 
concentrated marker gas. 
34. The device in accordance with claim 33, wherein said 
respiratory tract infection is a lower respiratory tract infec- 
tion. 
respiratory tract infection is an upper respiratory tract infec- 
tion. 
36, The device in accordance with claim 34, wherein said 
lower respiratory tract infection is selected from pneumonia 
or bronchitis. 
37. The device in accordance with claim 34, wherein said 
upper respiratory tract infection is selected from sinusitis or 
pharyngitis. 
38. A device for detecting a urinary tract infection by 
detecting an indicative marker gas, said device comprising: 40 
a) a sample chamber having a fluid inlet port for the influx 
of said indicative marker gas; 
b) a fluid concentrator in flow communication with said 
sample chamber, said fluid concentrator having an 
absorbent material capable of absorbing said indicative 45 
marker gas and capable of desorbing a concentrated 
indicative marker gas; and 
in fluid communication with said 
concentrated indicative marker gas. 
of said indicative marker gas; 
b) a fluid concentrator in flow communication with said 
sample chamber, said fluid concentrator having an 
absorbent material capable of absorbing said indicative 
marker gas and capable of desorbing a concentrated 
indicative marker gas; and 
c) an array of sensors in fluid communication with said 
concentrated indicative marker gas. 
43. The device in accordance with claim 42, wherein said 
indicative marker gas is an off gas from Enterobacteriaceae, 
Ente~Ococcus SP. and combinations thereof. 
44. A device for detecting the presence of an analyte, 
wherein said analyte is a marker gas indicative of bacterial 
vaginitis, said device comprising: 
a) a sample chamber having a fluid inlet port for the influx 
of said indicative marker gas; 
b) a fluid concentrator in flow communication with said 
sample chamber, said fluid concentrator having an 
absorbent material capable of absorbing said indicative 
marker gas and capable of desorbing a concentrated 
indicative marker gas; and 
c) an array of sensors in fluid communication with said 
concentrated indicative marker gas. 
.) an array of 45. The device in accordance with claim 44, wherein said 
indicative marker gas is selected from the group consisting 
39. The device in accordance with claim 38, wherein said 50 of methylamine, isobutylamine, putrescine, cadaverine, 
histamine, tyramine, and phenethylamine. 
35, The device in accordance with claim 33, wherein said 3o 
35 
indicative marker gas is a microorganism off gas selected 
from Enterobacteriaceae, Enterococcus sp. and combina- 
tions thereof. * * * * *  
